The New Promise for Weight Loss ?
Researchers are investigating retatrutide, a novel dual-agonist targeting both GLP-1 and GIP receptors. This compound demonstrates remarkable potential in facilitating a decrease in body mass. Early clinical trials suggest that retatrutide may offer enhanced efficacy compared to existing treatmen